Yeh, Chun-Nan <br/><br/>
Treatment of patients with advanced gastrointestinal stromal tumor of small bowel: implications of imatinib mesylate.  [electronic resource] 

 -  World journal of gastroenterology  Jun 2006 
 - 3760-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1007-9327 
<br/><br/><label>Standard No.: </label>10.3748/wjg.v12.i23.3760  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--adverse effects<br/>Benzamides<br/>Exons--genetics<br/>Female<br/>Gastrointestinal Stromal Tumors--drug therapy<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Imatinib Mesylate<br/>Intestinal Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Mutation<br/>Piperazines--adverse effects<br/>Platelet-Derived Growth Factor--genetics<br/>Prognosis<br/>Prospective Studies<br/>Proto-Oncogene Proteins c-kit--genetics<br/>Pyrimidines--adverse effects<br/>Survival Rate<br/>Treatment Outcome